Interleukin-6 (IL-6) has been identified as a critical cytokine in RA pathogenesis, disrupting both innate and adaptive immunity and promoting the production of acute-phase proteins responsible for systemic disease manifestations. This evidence concerns the gene IL6 and rheumatoid arthritis.